Localized proton spectroscopy of focal brain pathology in humans: Significant effects of edema on spin–spin relaxation time

Localized proton nuclear magnetic resonance (NMR) spectroscopy of human brain in two common focal pathologies producing brain edema (peritumor edema and acute edema–tous ischemic stroke) was performed utilizing point resolved spectroscopy (PRESS). The spectra obtained from the pathological tissues were characterized by a reduced N‐acetyl‐as–partate (NAA) to total creatine (Cr) ratio (NAA/Cr) and high level of lactate. While the spin lattice relaxation time (T1) of the main metabolite resonances, namely, those of NAA, Cr, and choline containing compounds (Cho), showed values similar to those of normal brain, the spin‐spin relaxation time (T2) of these metabolites exhibited a dramatic shortening in pathological tissues. Serial postoperative measurements of T2 in two patients with peritumor edema showed a gradual recovery of the T2 shortening corresponding to improvement of the edema. The majority of localized spectroscopy studies in humans is performed using a sequence which utilizes spin echo signals with a fixed single echo time. Hence, the signal intensities of the metabolite resonances obtained are inherently T2 dependent. The current study underscores that cautious interpretation of clinical data with respect to metabolite quantification is warranted.

[1]  O. Henriksen,et al.  In vivo relaxation of N-acetyl-aspartate, creatine plus phosphocreatine, and choline containing compounds during the course of brain infarction: a proton MRS study. , 1992, Magnetic resonance imaging.

[2]  J. Cooper,et al.  N‐ACETYL‐l‐ASPARTIC ACID CONTENT OF HUMAN NEURAL TUMOURS AND BOVINE PERIPHERAL NERVOUS TISSUES , 1972, Journal of neurochemistry.

[3]  H. Tallan,et al.  N-Acetyl-L-aspartic acid in brain. , 1956, The Journal of biological chemistry.

[4]  R G Shulman,et al.  Proton Magnetic Resonance Spectroscopy of Cerebral Lactate and Other Metabolites in Stroke Patients , 1992, Stroke.

[5]  G B Matson,et al.  Human brain infarction: proton MR spectroscopy. , 1992, Radiology.

[6]  P. Narayana,et al.  Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans. , 1990, Investigative radiology.

[7]  U. Klose,et al.  Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. , 1991, Radiology.

[8]  P A Narayana,et al.  In vivo proton magnetic resonance spectroscopy studies of human brain. , 1991, Magnetic resonance imaging.

[9]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[10]  P M Matthews,et al.  Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis , 1991, Neurology.

[11]  T. Nakada,et al.  Persistent high lactate level as a sensitive MR spectroscopy indicator of completed infarction. , 1990, Journal of neurosurgery.

[12]  S. Rose,et al.  Measurement of the T2 relaxation time of ethanol and cerebral metabolites, in vivo , 1992, Magnetic resonance in medicine.

[13]  George Fein,et al.  Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities , 1992, Magnetic resonance in medicine.

[14]  T. Richards Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. , 1991, AJR. American journal of roentgenology.